Rediscussion on linearity between fibrosis stages and mortality risk in nonalcoholic fatty liver disease patients

Zhengtao Liu^{1

2

3}, Shuping Que¹, Adil Mardinoglu^{1

4}

Affiliations

¹ Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.
² Key Laboratory of Combined Multi-Organ Transplantation Ministry of Public Health First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
³ Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
⁴ Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.

Comment

Zhengtao Liu et al. Hepatology. 2017 Oct.

. 2017 Oct;66(4):1357-1358.

doi: 10.1002/hep.29390. Epub 2017 Sep 4.

Zhengtao Liu^{1

2

3}, Shuping Que¹, Adil Mardinoglu^{1

4}

¹ Science for Life Laboratory, KTH-Royal Institute of Technology, Stockholm, Sweden.
² Key Laboratory of Combined Multi-Organ Transplantation Ministry of Public Health First Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China.
³ Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, China.
⁴ Department of Biology and Biological Engineering, Chalmers University of Technology, Gothenburg, Sweden.

No abstract available

Comment on

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis.
Dulai PS, Singh S, Patel J, Soni M, Prokop LJ, Younossi Z, Sebastiani G, Ekstedt M, Hagstrom H, Nasr P, Stal P, Wong VW, Kechagias S, Hultcrantz R, Loomba R. Dulai PS, et al. Hepatology. 2017 May;65(5):1557-1565. doi: 10.1002/hep.29085. Epub 2017 Mar 31. Hepatology. 2017. PMID: 28130788 Free PMC article.